Singapore markets open in 5 hours 49 minutes

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.83+0.08 (+0.19%)
As of 03:11PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts18182020
Avg. Estimate-1.71-1.58-6.58-5.24
Low estimate-2.13-1.84-7.51-6.83
High estimate-1.32-1.22-4.71-2.23
Year ago EPS-2.25-2.23-8.25-6.58
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17172021
Avg. Estimate122.64M132.69M511.74M632.2M
Low estimate108.5M121.9M501.5M559M
High estimate129.7M139.9M527.7M739M
Year ago sales108.31M98.05M434.25M511.74M
Sales growth (year/est)13.20%35.30%17.80%23.50%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.07-2.08-1.62-1.73
Actual EPS-2.25-2.23-1.52-2.03
Difference-0.18-0.150.1-0.3
Surprise %-8.70%-7.20%6.20%-17.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.71-1.58-6.58-5.24
7 days ago-1.64-1.59-6.45-5.04
30 days ago-1.63-1.58-6.44-4.96
60 days ago-1.63-1.58-6.45-4.9
90 days ago-1.6-1.5-6.28-4.35
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days2527
Up last 30 days47310
Down last 7 daysN/AN/AN/AN/A
Down last 30 days9695
Growth estimatesRAREIndustrySector(s)S&P 500
Current qtr.24.00%N/AN/AN/A
Next qtr.29.10%N/AN/AN/A
Current year20.20%N/AN/AN/A
Next year20.40%N/AN/AN/A
Next 5 years (per annum)8.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A